Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 Nov-Dec;5(6):828–831. doi: 10.3201/eid0506.990616

Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.

A E Fiore 1, O S Levine 1, J A Elliott 1, R R Facklam 1, J C Butler 1
PMCID: PMC2640808  PMID: 10603221

Abstract

To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age. Effectiveness against invasive disease caused by serotypes included in the vaccine was 63%. Effectiveness against serotypes in the polysaccharide vaccine but not in a proposed seven-valent protein conjugate vaccine was 94%.

Full Text

The Full Text of this article is available as a PDF (94.7 KB).


Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES